SFX by Ex Libris Inc.

Title:	The Quantitative Prediction of CYP-mediated Drug Interaction by Physiologically Based Pharmacokinetic Modeling
Source:	Pharmaceutical Research [0724-8741] Kato, Motohiro yr:2008

Basic

Full text

Full text available via SpringerLINK Contemporary 1997-Present

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Xia, B. "Physiologically based pharmacokinetic modeling for assessing the clinical drugâdrug interaction of alisporivir." European journal of pharmaceutical sciences 63 (2014): 103-112.
description	2.	Kis, O. "The complexities of antiretroviral drug-drug interactions: role of ABC and SLC transporters." Trends in Pharmacological Sciences 31.1 (2010): 22-35.
description	3.	Nina, I. "Qualitative Analysis of the Role of Metabolites in Inhibitory Drug−Drug Interactions: Literature Evaluation Based on the Metabolism and Transport Drug Interaction Database." Chemical research in toxicology 22.2 (2009): 294-8.
description	4.	Friedrich, O. "NA+- and K+-channels as molecular targets of the alkaloid ajmaline in skeletal muscle fibres." British journal of pharmacology 151.1 (2007): 82-93.
description	5.	Han, B. "Optimization of drug-drug interaction study design: comparison of minimal physiologically based pharmacokinetic models on prediction of CYP3A inhibition by ketoconazole." Drug metabolism and disposition 41.7 (2013): 1329-1338.
description	6.	Tekes, K. "Aliphatic and aromatic oxidations, epoxidation and s-oxidation of prodrugs that yield active drug metabolites." Current medicinal chemistry 18.32 (2011): 4885-4900.
description	7.	Fink, S. "Differential effects of alkaloids on sodium currents of isolated single skeletal muscle fibers." FEBS letters 436.2 (1998): 251-255.
description	8.	PEHEK, E. "DISCRIMINATIVE STIMULUS PROPERTIES OF (+)CATHINE, AN ALKALOID OF THE KHAT PLANT." Pharmacology, biochemistry and behavior 36.2 (1990): 267-271.
description	9.	Adachi, A. "Generation of cyanide ion by the reaction of hexamine and losartan potassium with sodium hypochlorite." Journal of healthscience 54.5 (2008): 581-583.
description	10.	Espina, R. "Nuclear Magnetic Resonance Spectroscopy as a Quantitative Tool To Determine the Concentrations of Biologically Produced Metabolites: Implications in Metabolites in Safety Testing." Chemical research in toxicology 22.2 (2009): 299-310.
description	11.	Somogyi, A A. "CYP3A4 mediates dextropropoxyphene N-demethylation to nordextropropoxyphene: Human in vitro and in vivo studies and lack of CYP2D6 involvement." Xenobiotica 34.10 (2004): 875-887.
description	12.	Kim, R B B. "The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors." The journal of clinical investigation 101.2 (1997): 289-94.
description	13.	Bassetti, S. "Access to antiretroviral therapy." JAMA 283.7 (2000): 883-884.
description	14.	Davidoff, M. "Degeneration and restoration of spermatogenesis in relation to the changes in Leydig cell population following ethane dimethanesulfonate treatment in adult rats." Endocrine regulations 35.4 (2002): 209-15.
description	15.	Kuethe, Jeffrey T. "Aza-Diels-Alder/intramolecular Heck cyclization approach to the tetrahydro-Î²-carboline skeleton of the ajmaline/sarpagine alkaloids." Tetrahedron letters 43.21 (2002): 3871-3874.
description	16.	De Clercq, E. "Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy." British journal of pharmacology 147.1 (2006): 1-11.
description	17.	Wang, T. "Stereocontrolled total synthesis of alkaloid G via the oxy-anion cope rearrangement and improved total synthesis of (+)-ajmaline." Organic letters 3.3 (2001): 345-348.
description	18.	Rolf, S. "The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol." European heart journal 24.12 (2003): 1104-12.
description	19.	McIlleron, H. "Complications of antiretroviral therapy in patients with tuberculosis: Drug interactions, toxicity, and immune reconstitution inflammatory syndrome." The journal of infectious diseases 196.SUPPL 1 (2007): -75.
description	20.	Sheridan, Robert P. "Empirical Regioselectivity Models for Human Cytochromes P450 3A4, 2D6, and 2C9." Journal of medicinal chemistry 50.14 (2007): 3173-3184.